Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Renwick

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Investigative Ophthalmology & Visual Science|October 23, 2018
A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye - Implications for Ocular Gene TherapyShyamtanu Datta, Marian Renwick, Viet Q Chau, et al.
Cell Death & Disease|November 6, 2025
Genetic removal of Nlrp3 protects against age-related and R345W Efemp1-induced basal laminar deposit formationAntonio J Ortega, Steffi Daniel, Marian Renwick, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Genetic removal of Nlrp3 protects against sporadic and R345W Efemp1-induced basal laminar deposit formationAntonio J Ortega, Steffi Daniel, Marian Renwick, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 23, 2020
Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integritySteffi Daniel, Marian Renwick, Viet Q Chau, et al.
Iscience|May 6, 2022
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and agingHui Peng, Prerana Ramadurgum, DaNae R Woodard, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains <i>In Vivo</i>Hui Peng, Viet Q Chau, Wanida Phetsang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Investigative Ophthalmology & Visual Science|October 23, 2018
A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye - Implications for Ocular Gene TherapyShyamtanu Datta, Marian Renwick, Viet Q Chau, et al.
Cell Death & Disease|November 6, 2025
Genetic removal of Nlrp3 protects against age-related and R345W Efemp1-induced basal laminar deposit formationAntonio J Ortega, Steffi Daniel, Marian Renwick, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Genetic removal of Nlrp3 protects against sporadic and R345W Efemp1-induced basal laminar deposit formationAntonio J Ortega, Steffi Daniel, Marian Renwick, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 23, 2020
Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integritySteffi Daniel, Marian Renwick, Viet Q Chau, et al.
Iscience|May 6, 2022
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and agingHui Peng, Prerana Ramadurgum, DaNae R Woodard, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains <i>In Vivo</i>Hui Peng, Viet Q Chau, Wanida Phetsang, et al.
Pageof 1